COVID-19 Ricochets on Kidney Transplant and Hemodialysis Patients

Authors : Mevlüt Hakan GÖKTEPE, Hilal AKAY ÇİZMECİOGLU, Ali Kürşat TUNA, Ahmet CİZMECİOGLU
Pages : 309-315
Doi:10.54005/geneltip.1251579
View : 136 | Download : 98
Publication Date : 2023-06-30
Article Type : Research Paper
Abstract :Background/Aims: An impaired immune response affects Coronavirus 2019 insert ignore into journalissuearticles values(COVID-19); disease progression. Immunities of both hemodialysis insert ignore into journalissuearticles values(HD); and Kidney Transplant insert ignore into journalissuearticles values(KTx); patients have already been suppressed. This study evaluated the prognostic laboratory results in HD and KTx patients with COVID-19. Methods: This retrospective, case-control study was conducted with PCR insert ignore into journalissuearticles values(+); COVID-19 HD and KTx patients and a control group. All patients were divided into two subgroups according to disease severity. Patients\` demographic records and laboratory results were obtained from the follow-up files. Results: A total of 30 HD, 20 KTx patients, and 40 control groups were involved in the study. Gender and hospitalization duration did not differ between the groups. There was a 10% mortality rate in the KTx group and 27% in the HD group. Lung involvement in Computed Tomography insert ignore into journalissuearticles values(CT); was higher in HD patients insert ignore into journalissuearticles values(47%); than in KTx insert ignore into journalissuearticles values(25%);. In subgroup evaluations, the most prominent laboratory values were fibrinogen in HD patients and LDH and Ferritin in KTx patients in determining disease severity. Conclusions: Early hospitalization and treatment implementations will be associated with a good prognosis in HD and KTx patients since CT and laboratory results are not predictive in these groups of patients during the COVID-19 pandemic.
Keywords : COVID 19, Böbrek nakli, Hemodiyaliz, Hastalık şiddeti

ORIGINAL ARTICLE URL